Your browser doesn't support javascript.
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
1.
J Virol ; 96(17): e0077222, 2022 09 14.
Artículo en Inglés | MEDLINE | ID: covidwho-1992939

RESUMEN

Bats are reservoirs for diverse coronaviruses, including swine acute diarrhea syndrome coronavirus (SADS-CoV). SADS-CoV was first identified in diarrheal piglets in 2017. As a novel alphacoronavirus, SADS-CoV shares ~95% identity with bat alphacoronavirus HKU2. SADS-CoV has been reported to have broad cell tropism and inherent potential to cross host species barriers for dissemination. Thus far, no effective antiviral drugs or vaccines are available to treat infections with SADS-CoV. Therefore, knowledge of the protein-coding gene set and a subcellular localization map of SADS-CoV proteins are fundamental first steps in this endeavor. Here, all SADS-CoV genes were cloned separately into Flag-tagged plasmids, and the subcellular localizations of viral proteins, with the exception of nsp11, were detected using confocal microscopy techniques. As a result, nsp1, nsp3-N, nsp4, nsp5, nsp7, nsp8, nsp9, nsp10, nsp14, and nsp15 were localized in the cytoplasm and nuclear spaces, and these viral proteins may perform specific functions in the nucleus. All structural and accessory proteins were mainly localized in the cytoplasm. NS7a and membrane protein M colocalized with the Golgi compartment, and they may regulate the assembly of SADS-CoV virions. Maturation of SADS-CoV may occur in the late endosomes, during which envelope protein E is involved in the assembly and release of the virus. In summary, the present study demonstrates for the first time the location of all the viral proteins of SADS-CoV. These fundamental studies of SADS-CoV will promote studies of basic virology of SADS-CoV and support preventive strategies for animals with infection of SADS-CoV. IMPORTANCE SADS-CoV is the first documented spillover of a bat coronavirus that causes severe diseases in domestic animals. Our study is an in-depth annotation of the newly discovered swine coronavirus SADS-CoV genome and viral protein expression. Systematic subcellular localization of SADS-CoV proteins can have dramatic significance in revealing viral protein biological functions in the subcellular locations. Furthermore, our study promote understanding the fundamental science behind the novel swine coronavirus to pave the way for treatments and cures.


Asunto(s)
Alphacoronavirus , Infecciones por Coronavirus , Enfermedades de los Porcinos , Proteínas Virales , Alphacoronavirus/genética , Animales , Núcleo Celular/virología , Quirópteros , Infecciones por Coronavirus/veterinaria , Endosomas/virología , Aparato de Golgi/virología , Porcinos , Enfermedades de los Porcinos/virología , Proteínas Virales/genética
3.
Pharmacol Res Perspect ; 9(4): e00798, 2021 08.
Artículo en Inglés | MEDLINE | ID: covidwho-1269136

RESUMEN

Therapeutic regimens for the COVID-19 pandemics remain unmet. In this line, repurposing of existing drugs against known or predicted SARS-CoV-2 protein actions have been advanced, while natural products have also been tested. Here, we propose that p-cymene, a natural monoterpene, can act as a potential novel agent for the treatment of SARS-CoV-2-induced COVID-19 and other RNA-virus-induced diseases (influenza, rabies, Ebola). We show by extensive molecular simulations that SARS-CoV-2 C-terminal structured domain contains a nuclear localization signal (NLS), like SARS-CoV, on which p-cymene binds with low micromolar affinity, impairing nuclear translocation of this protein and inhibiting viral replication, as verified by preliminary in vitro experiments. A similar mechanism may occur in other RNA-viruses (influenza, rabies and Ebola), also verified in vitro for influenza, by interaction of p-cymene with viral nucleoproteins, and structural modification of their NLS site, weakening its interaction with importin A. This common mechanism of action renders therefore p-cymene as a possible antiviral, alone, or in combination with other agents, in a broad spectrum of RNA viruses, from SARS-CoV-2 to influenza A infections.


Asunto(s)
Antivirales/farmacología , Cimenos/farmacología , Subtipo H1N1 del Virus de la Influenza A/fisiología , Proteínas de la Nucleocápside/metabolismo , SARS-CoV-2/fisiología , Animales , Antivirales/química , Núcleo Celular/metabolismo , Núcleo Celular/virología , Chlorocebus aethiops , Cimenos/química , Perros , Humanos , Subtipo H1N1 del Virus de la Influenza A/efectos de los fármacos , Células de Riñón Canino Madin Darby , Modelos Moleculares , Simulación de Dinámica Molecular , Señales de Localización Nuclear , Proteínas de la Nucleocápside/química , Conformación Proteica , Dominios Proteicos , Transporte de Proteínas , SARS-CoV-2/efectos de los fármacos , Células Vero , Replicación Viral/efectos de los fármacos
4.
Cells ; 10(6)2021 06 07.
Artículo en Inglés | MEDLINE | ID: covidwho-1259432

RESUMEN

The host nucleocytoplasmic trafficking system is often hijacked by viruses to accomplish their replication and to suppress the host immune response. Viruses encode many factors that interact with the host nuclear transport receptors (NTRs) and the nucleoporins of the nuclear pore complex (NPC) to access the host nucleus. In this review, we discuss the viral factors and the host factors involved in the nuclear import and export of viral components. As nucleocytoplasmic shuttling is vital for the replication of many viruses, we also review several drugs that target the host nuclear transport machinery and discuss their feasibility for use in antiviral treatment.


Asunto(s)
Núcleo Celular/metabolismo , Núcleo Celular/virología , SARS-CoV-2/fisiología , Fenómenos Fisiológicos de los Virus , Replicación Viral/fisiología , Transporte Activo de Núcleo Celular/fisiología , COVID-19/metabolismo , COVID-19/virología , Interacciones Huésped-Patógeno/fisiología , Humanos , Proteínas de Transporte Nucleocitoplasmático/metabolismo , Internalización del Virus , Virus/patogenicidad
5.
Biochem Biophys Res Commun ; 536: 59-66, 2021 01 15.
Artículo en Inglés | MEDLINE | ID: covidwho-971357

RESUMEN

The novel human betacoronavirus SARS-CoV-2 has caused an unprecedented pandemic in the 21st century. Several studies have revealed interactions between SARS-CoV-2 viral proteins and host nucleoporins, yet their functions are largely unknown. Here, we demonstrate that the open-reading frame 6 (ORF6) of SARS-CoV-2 can directly manipulate localization and functions of nucleoporins. We found that ORF6 protein disrupted nuclear rim staining of nucleoporins RAE1 and NUP98. Consequently, this disruption caused aberrant nucleocytoplasmic trafficking and led to nuclear accumulation of mRNA transporters such as hnRNPA1. Ultimately, host cell nucleus size was reduced and cell growth was halted.


Asunto(s)
Tamaño del Núcleo Celular , Proteínas Asociadas a Matriz Nuclear/metabolismo , Proteínas de Complejo Poro Nuclear/metabolismo , Proteínas de Transporte Nucleocitoplasmático/metabolismo , Proteínas Virales/metabolismo , Transporte Activo de Núcleo Celular , Núcleo Celular/virología , Células HEK293 , Ribonucleoproteína Nuclear Heterogénea A1/metabolismo , Humanos , SARS-CoV-2
6.
J Virol ; 94(6)2020 02 28.
Artículo en Inglés | MEDLINE | ID: covidwho-827743

RESUMEN

TER94 is a multifunctional AAA+ ATPase crucial for diverse cellular processes, especially protein quality control and chromatin dynamics in eukaryotic organisms. Many viruses, including coronavirus, herpesvirus, and retrovirus, coopt host cellular TER94 for optimal viral invasion and replication. Previous proteomics analysis identified the association of TER94 with the budded virions (BVs) of baculovirus, an enveloped insect large DNA virus. Here, the role of TER94 in the prototypic baculovirus Autographa californica multiple nucleopolyhedrovirus (AcMNPV) life cycle was investigated. In virus-infected cells, TER94 accumulated in virogenic stroma (VS) at the early stage of infection and subsequently partially rearranged in the ring zone region. In the virions, TER94 was associated with the nucleocapsids of both BV and occlusion-derived virus (ODV). Inhibition of TER94 ATPase activity significantly reduced viral DNA replication and BV production. Electron/immunoelectron microscopy revealed that inhibition of TER94 resulted in the trapping of nucleocapsids within cytoplasmic vacuoles at the nuclear periphery for BV formation and blockage of ODV envelopment at a premature stage within infected nuclei, which appeared highly consistent with its pivotal function in membrane biogenesis. Further analyses showed that TER94 was recruited to the VS or subnuclear structures through interaction with viral early proteins LEF3 and helicase, whereas inhibition of TER94 activity blocked the proper localization of replication-related viral proteins and morphogenesis of VS, providing an explanation for its role in viral DNA replication. Taken together, these data indicated the crucial functions of TER94 at multiple steps of the baculovirus life cycle, including genome replication, BV formation, and ODV morphogenesis.IMPORTANCE TER94 constitutes an important AAA+ ATPase that associates with diverse cellular processes, including protein quality control, membrane fusion of the Golgi apparatus and endoplasmic reticulum network, nuclear envelope reformation, and DNA replication. To date, little is known regarding the role(s) of TER94 in the baculovirus life cycle. In this study, TER94 was found to play a crucial role in multiple steps of baculovirus infection, including viral DNA replication and BV and ODV formation. Further evidence showed that the membrane fission/fusion function of TER94 is likely to be exploited by baculovirus for virion morphogenesis. Moreover, TER94 could interact with the viral early proteins LEF3 and helicase to transport and further recruit viral replication-related proteins to establish viral replication factories. This study highlights the critical roles of TER94 as an energy-supplying chaperon in the baculovirus life cycle and enriches our knowledge regarding the biological function of this important host factor.


Asunto(s)
Adenosina Trifosfatasas/metabolismo , Nucleocápside/metabolismo , Nucleopoliedrovirus/fisiología , Replicación Viral , Animales , Núcleo Celular/virología , Citoplasma/virología , ADN Helicasas/metabolismo , ADN Viral/biosíntesis , Proteínas de Unión al ADN/metabolismo , Interacciones Huésped-Patógeno , Células Sf9/virología , Vacuolas/virología , Proteínas Virales/metabolismo , Virión
7.
Platelets ; 31(8): 1085-1089, 2020 Nov 16.
Artículo en Inglés | MEDLINE | ID: covidwho-733448

RESUMEN

Coronavirus disease 2019 (COVID-19) is a global public health emergency with many clinical facets, and new knowledge about its pathogenetic mechanisms is deemed necessary; among these, there are certainly coagulation disorders. In the history of medicine, autopsies and tissue sampling have played a fundamental role in order to understand the pathogenesis of emerging diseases, including infectious ones; compared to the past, histopathology can be now expanded by innovative techniques and modern technologies. For the first time in worldwide literature, we provide a detailed postmortem and biopsy report on the marked increase, up to 1 order of magnitude, of naked megakaryocyte nuclei in the bone marrow and lungs from serious COVID-19 patients. Most likely related to high interleukin-6 serum levels stimulating megakaryocytopoiesis, this phenomenon concurs to explain well the pulmonary abnormal immunothrombosis in these critically ill patients, all without molecular or electron microscopy signs of megakaryocyte infection.


Asunto(s)
Betacoronavirus/patogenicidad , Médula Ósea/patología , Infecciones por Coronavirus/patología , Síndrome de Liberación de Citoquinas/patología , Coagulación Intravascular Diseminada/patología , Pulmón/patología , Neumonía Viral/patología , Trombosis/patología , Adulto , Anciano , Autopsia , Betacoronavirus/inmunología , Médula Ósea/inmunología , Médula Ósea/virología , COVID-19 , Núcleo Celular/inmunología , Núcleo Celular/patología , Núcleo Celular/virología , Infecciones por Coronavirus/complicaciones , Infecciones por Coronavirus/inmunología , Infecciones por Coronavirus/virología , Enfermedad Crítica , Síndrome de Liberación de Citoquinas/complicaciones , Síndrome de Liberación de Citoquinas/inmunología , Síndrome de Liberación de Citoquinas/virología , Coagulación Intravascular Diseminada/complicaciones , Coagulación Intravascular Diseminada/inmunología , Coagulación Intravascular Diseminada/virología , Resultado Fatal , Interacciones Huésped-Patógeno/inmunología , Humanos , Interleucina-6/biosíntesis , Interleucina-6/inmunología , Pulmón/inmunología , Pulmón/virología , Masculino , Megacariocitos/inmunología , Megacariocitos/patología , Megacariocitos/virología , Persona de Mediana Edad , Pandemias , Neumonía Viral/complicaciones , Neumonía Viral/inmunología , Neumonía Viral/virología , SARS-CoV-2 , Índice de Severidad de la Enfermedad , Trombopoyesis/inmunología , Trombosis/complicaciones , Trombosis/inmunología , Trombosis/virología
8.
Drug Discov Today ; 25(10): 1775-1781, 2020 10.
Artículo en Inglés | MEDLINE | ID: covidwho-611872

RESUMEN

Coronavirus 2019 (COVID-19; caused by Severe Acute Respiratory Syndrome Coronavirus 2; SARS-CoV-2) is a currently global health problem. Previous studies showed that blocking nucleocytoplasmic transport with exportin 1 (XPO1) inhibitors originally developed as anticancer drugs can quarantine key viral accessory proteins and genomic materials in the nucleus of host cell and reduce virus replication and immunopathogenicity. These observations support the concept of the inhibition of nuclear export as an effective strategy against an array of viruses, including influenza A, B, and SARS-CoV. Clinical studies using the XPO1 inhibitor selinexor as a therapy for COVID-19 infection are in progress.


Asunto(s)
Antivirales/uso terapéutico , Tratamiento Farmacológico de COVID-19 , Núcleo Celular/efectos de los fármacos , Diseño de Fármacos , Carioferinas/antagonistas & inhibidores , Receptores Citoplasmáticos y Nucleares/antagonistas & inhibidores , SARS-CoV-2/patogenicidad , Transporte Activo de Núcleo Celular , Animales , COVID-19/inmunología , COVID-19/metabolismo , COVID-19/virología , Núcleo Celular/inmunología , Núcleo Celular/metabolismo , Núcleo Celular/virología , Interacciones Huésped-Patógeno , Humanos , Carioferinas/metabolismo , Terapia Molecular Dirigida , Receptores Citoplasmáticos y Nucleares/metabolismo , SARS-CoV-2/inmunología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA